rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Andrew I. Koven

Director

Company insider

Files Form 4 as: Director, MetaVia; Director, Kala Bio; President & Chief Business Off, Aralez Pharmaceuticals; President, Chief Business Ofc., Pozen Inc /nc; EVP, CAO, GC and Secretary, Auxilium Pharmaceuticals; Director and Officer, Neurologix Inc/de; EVP & Chief Admin & Legal Ofc, Inspire Pharmaceuticals; Exec VP, General Counsel, Sepracor Inc /de/.

Every Form 4 they filed

In numbers

Trades disclosed
97
Buys
2
Sells
6
Bought
$301K
Sold
$5.0M
Companies
9
Companies where not an officer
2
First trade
26 Jan 2006
Last trade
8 Jun 2026
Last filed
8 Jun 2026

Companies traded

Where they are an officer
Aralez PharmaceuticalsOfficer · last 4 Jun 20182 buys · 5 sells
Pozen Inc /ncOfficer · last 3 Jun 20150 buys · 0 sells
Auxilium PharmaceuticalsOfficer · last 29 Jan 20150 buys · 1 sell
Neurologix Inc/deDirector, Officer · last 19 Sep 20110 buys · 0 sells
Inspire PharmaceuticalsOfficer · last 13 May 20110 buys · 0 sells
Sepracor Inc /de/Officer · last 20 Oct 20090 buys · 0 sells
Kos PharmaceuticalsOfficer · last 13 Dec 20060 buys · 0 sells
Everywhere else they filed: board seats, 10% stakes, other companies
MTVA MetaViaDirector · Biotechnology · last 8 Jun 20260 buys · 0 sells
KALA Kala BioDirector · Biotechnology · last 15 Jun 20250 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
8 Jun 2026filed 8 Jun 2026MTVA MetaViaBiotechnologySEC FORM 4 Code A—17,186 at $0.00filing
8 Jun 2026filed 8 Jun 2026MTVA MetaViaBiotechnologySEC FORM 4 Code A—17,186 at $0.00filing
30 Jun 2025filed 1 Jul 2025MTVA MetaViaBiotechnologySEC FORM 4 Code A—28,147 at $0.00filing
15 Jun 2025filed 17 Jun 2025KALA Kala Biooption or derivative · BiotechnologySEC FORM 4 Code A—6,850 at $0.00filing
15 Jun 2025filed 17 Jun 2025KALA Kala BioBiotechnologySEC FORM 4 Code A—3,050 at $0.00filing
11 Jun 2024filed 12 Jun 2024KALA Kala Biooption or derivative · BiotechnologySEC FORM 4 Code A—3,900 at $0.00filing
11 Jun 2024filed 12 Jun 2024KALA Kala BioBiotechnologySEC FORM 4 Code A—1,750 at $0.00filing
7 Jun 2024filed 7 Jun 2024MTVA MetaViaBiotechnologySEC FORM 4 Code A—5,051 at $0.00filing
27 Jul 2023filed 28 Jul 2023MTVA MetaViaBiotechnologySEC FORM 4 Code A—87,500 at $0.00filing
27 Jul 2023filed 28 Jul 2023MTVA MetaViaBiotechnologySEC FORM 4 Code A—12,500 at $0.00filing
22 Jun 2023filed 23 Jun 2023KALA Kala Biooption or derivative · BiotechnologySEC FORM 4 Code A—10,020 at $0.00filing
22 Jun 2023filed 23 Jun 2023KALA Kala Biooption or derivative · BiotechnologySEC FORM 4 Code A—3,150 at $0.00filing
22 Jun 2023filed 23 Jun 2023KALA Kala BioBiotechnologySEC FORM 4 Code A—7,515 at $0.00filing
22 Jun 2023filed 23 Jun 2023KALA Kala BioBiotechnologySEC FORM 4 Code A—1,400 at $0.00filing
31 May 2023filed 2 Jun 2023KALA Kala Biooption or derivative · BiotechnologySEC FORM 4 Code D—518filing
31 May 2023filed 2 Jun 2023KALA Kala Biooption or derivative · BiotechnologySEC FORM 4 Code D—259filing
31 May 2023filed 2 Jun 2023KALA Kala Biooption or derivative · BiotechnologySEC FORM 4 Code D—420filing
31 May 2023filed 2 Jun 2023KALA Kala Biooption or derivative · BiotechnologySEC FORM 4 Code D—1,000filing
31 May 2023filed 2 Jun 2023KALA Kala BioBiotechnologySEC FORM 4 Code A—2,197filing
16 Jun 2022filed 17 Jun 2022KALA Kala Biooption or derivative · BiotechnologySEC FORM 4 Code A—50,000 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Not placed8

Buys in green, sells in red, by the company’s sector.

Related people

Nobody else traded the same names lately.